Sharon Murphy

Lassitude

Lassitude, my GP called it in his letter to the specialist at the time of my diagnosis.  Please see Sharon for her hepatitis C.  Symptoms include lassitude.  I went home and looked it up in the dictionary.

Lassitude:  n. a state or feeling of weariness, diminished energy, or listlessness.

The truth was the word barely touched the edges of how I was feeling.  It was 2003, September, and while I was happy to have an explanation for what I was experiencing, I was exhausted and very afraid. 

I knew nothing about hepatitis C but I sensed my life would never be the same.

Six months later I saw the specialist and decided to go on treatment.  I learned I had genotype 1 which meant 48 weeks of combination therapy.  I was pleased I was able to access the new ‘pegylated’ interferon. 

I was completely unprepared for what was to come.  I got reclusive and depressed but I persevered.  Completing treatment was one of my proudest accomplishments.

During my treatment I discovered a peer-support online forum.  I became part of a community of people who were going through treatment too and feeling much like I was. 

The friendships I formed then remain strong to this day. 

Four months after I completed treatment, in October 2005, I saw my specialist to review the results of my blood tests.  I’ll never forget hearing his words.  “It doesn’t look good” I didn’t understand what he meant at first because I had never contemplated the possibility of a relapse.  Sadly, a PCR confirmed the virus had returned.  I was devastated.

I relied heavily on the support of my friends on the peer support website to get me through the difficult period that followed.  I didn’t know how I would be able to recover and create a new life that included the virus.  I saw counsellors and social workers and I slowly started moving forward.

One year later I had a liver biopsy which showed I had level 3 fibrosis with ‘pre-cirrhosis.’  That scared me and gave me the motivation to make some necessary changes.  I stopped drinking alcohol completely and changed my diet.  I made the decision to minimize the stress in my life. My health and outlook improved remarkably.

In 2007 I joined the board of my state hepatitis council.  I work part time at a Needle Syringe Program, distributing sterile injecting equipment to drug users to prevent the spread of blood-borne viruses.  I am involved with a positive speakers’ bureau and have attended hepatitis conferences. 

I was right; hepatitis C has changed my life.  I have over the last few years forged a life with a quality I couldn’t have imagined at the time I got the news I had relapsed.

As for the lassitude, I still get it, but it’s manageable, most of the time.  I take care of myself and the virus behaves.

Share your story now

For people living with a hepatitis condition, it really helps to know they’re not alone. That’s why we’re inviting people to share their stories.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close